GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Cash Flow from Others

K Pharma (TSE:4896) Cash Flow from Others : 円0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Cash Flow from Others?

K Pharma's cash flow from others for the three months ended in Mar. 2024 was 円0 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil.


K Pharma Cash Flow from Others Historical Data

The historical data trend for K Pharma's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Cash Flow from Others Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow from Others
9.53 36.23 63.15

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Cash Flow from Others Get a 7-Day Free Trial - - - - -

K Pharma Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

K Pharma Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of K Pharma's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines